Robert Palmer

Robert Palmer

Founder and Chief Executive Officer

“Driven by my father’s battle with cancer, I am committed to empowering patients and families with the personalized information they need to make informed decisions, improving both quality and length of life.”

Robert is CEO, founder, visionary and lead architect of PotentiaMetrics products, including Ardynn and Capire360. He is responsible for team and company leadership.

Robert Palmer has spent over two decades solving one of healthcare’s most persistent problems: that the outcomes data available to clinicians and patients reflects what happens to populations, not individuals. His work on that problem, from early outcomes research and enterprise sales to building the company purpose makes him one of the few people in health technology who has developed the science, sold it at the highest levels, and is now building the category around it

Palmer began developing combined clinical and economic outcomes models in 2005 in collaboration with cardiothoracic surgeons he later worked as a researcher and consultant co- Washington University School of Medicine in St. Louis developing personalized cancer care models. That work became the foundation of Capire360, PotentiaMetrics’ precision analytics engine. He served as adjunct faculty in Washington University’s Olin School of Business entrepreneurship program from 2007 to 2013. His work has been published in the Harvard Health Policy Review and recognized by GuideWell Innovation, the American Cancer Society. He has presented at McKinsey’s Annual Healthcare Conference, Predictive Analytics World Conference, South by Southwest and other forums.

His commercial track record is equally substantive. Palmer personally led and closed a national contract with UnitedHealthcare, one of the most demanding enterprise sales environments in the industry, and has completed significant engagements with Medtronic, Ascension Health, Covidien, Sorin, and multiple health systems and medical schools. He has structured and executed data-sharing agreements with hospital systems and medical schools. He has sold successfully on both the payer and provider sides of the market, which is uncommon and operationally significant for a company whose distribution strategy spans both.

The mission is personal. Palmer’s father died from metastatic prostate cancer, navigating treatment decisions without the kind of individualized outcomes information PotentiaMetrics now produces. It is why the company exists.

Palmer holds an MBA from Washington University’s Olin School of Business and a BS in Business Administration from Regis University. He is a former member of the Young Presidents Organization and served as Education Chair for the YPO Healthcare Network.

Jerry Henderson

Jerry Henderson, MD

Chief Medical Officer

“For over a decade, I ran the cancer-only ER at MD Anderson, where I witnessed countless patients blindsided by side effects of treatment. When I became Director of Informatics, I was appalled by the staggering costs of treatments that frequently failed to extend or enhance life. When I encountered the Capire360 model, I recognized its potential to help patients. I’ve committed to enhancing its application and making it a standard of care.”

Jerry is responsible for the clinical data registries and analytics platforms that power Capire360. He works closely with Ardynn’s team of advocates, ensuring they have all the tools they need to best support members.

Dr. Henderson is a practicing oncologic emergency medicine doctor. He was formerly Chair of both the Informatics Governance and the Inpatient Clinical Informatics Committees at MD Anderson. In his time at MD Anderson, he designed and implemented the Oncologic Emergency Medicine fellowship, the first of its kind in the world, as well as a software program called Zero-G, receiving him the Innovator of the Year Award in 2013.

Dr. Henderson earned his medical degree from Royal College of Surgeons in Ireland, and completed his residency at University of Texas Galveston. He has continued education, earning an MBA from Rice University, and attended the Harvard Business School Executive Education Value Measurement in Healthcare program.

Sal Calta

Sal Calta

Chief Operating Officer

”The modern health care system is so complex that it’s almost impossible for the average person to navigate all the decisions required to successfully deal with a cancer diagnosis. Ardynn is the perfect solution to help anyone navigate through those complexities and make the right choices consistent with their goals and values. Some of us are lucky enough to have a friend or family member “inside” the healthcare system who can help us navigate. Now EVERYONE has that friend or family member with Ardynn!”

Sal is responsible for all aspects of day-to-day operations, including product delivery, enhancements, and support, as well as the back-office functions of Finance, HR, and Compliance.

Sal brings extensive experience in information technology and business transformation. Sal was a Senior Executive at IBM (most recently the VP of Business Transformation), retiring in 2015. Sal then served as the interim CIO at Florida Blue, focusing on healthcare innovation.

Sheri Rodriguez, EdD(c), MA

Chief Growth Officer

Sheri leads business development and strategic initiatives at PotentiaMetrics, supporting the organization’s growth strategy through identification and advancement of high-value opportunities aligned with the company’s analytics-driven solutions for value-based care. She brings a disciplined, relationship-driven approach to executive engagement, strategic positioning, and opportunity development, helping align customer needs with PotentiaMetrics’ capabilities to support sustainable results.
 

Sheri is a healthcare leader with deep expertise in population health, managed care, ACO/CIN network development, and value-based programs. Prior to joining PotentiaMetrics, she held leadership roles within large, multi-market health systems and health plans, where she directed enterprise network strategy, payer and provider contracting, and government program operations. Her work focused on strengthening network performance, improving financial and quality outcomes, and translating complex value-based strategies into effective execution.

Christopher Louden

Christopher Louden

Vice President of Data Science

“I am dedicated to arming people with cancer with sufficient information to amplify their voices in decisions about their treatment.”

Chris is responsible for all things data. He leads Capire360’s model development, architecture, and data management. 



Chris is a statistician with extensive experience with the intersection of machine learning and oncology building statistical models. He is highly skilled in data science, statistics and programming, with a vast experience and expertise in data science and biostatistics in both the healthcare and IT industries. For the better part of a decade he served as an independent statistical consultant in the IT and medical industries.



His previous roles include data scientist at HP and Senior Biostatistician for University of Texas Health Science Center San Antonio.

Christin Palmer

Christin Palmer

Dir. of Brand Experience & Member Success

“Having witnessed several loved ones battle cancer, I am deeply passionate about our work. People with cancer deserve transparency. They need someone in their corner willing to have difficult conversations, and arm them with the facts and data to make the right decisions about when to keep fighting and when to prioritize quality of life.”

Christin is responsible for leading the company’s branding initiatives, ensuring brand consistency, and providing the sales and marketing teams with the tools and strategies needed for success. Since joining the company in 2017, Christin has consistently demonstrated a passion for empowering the sales and marketing teams and commitment to contributing to member experience and the company’s growth and evolution.
Dana Hutson

Dana Hutson

Lead Advocate

”After experiencing the dysfunction of the healthcare system first hand while navigating my Father’s cancer diagnosis it became clear that people need help. No one should go through a cancer diagnosis without the guidance of a subject matter expert.”

Dana brings a wealth of oncology experience with a 24-year career in oncology biopharmaceutical sales and private advocacy, as well as personal experience navigating a loved one’s cancer.

In 2015, Dana’s father was diagnosed with an aggressive form of the disease. As she supported her family during this difficult time, she kept wondering “how do people without knowledge of the medical maze manage all of this?” She realized people with cancer needed a person they could trust to both advise and help them through their cancer journey.

Motivated by this realization, Dana earned her credentials as a Patient Advocacy Board (PACB) certified advocate. With her warm personality and vast experience, she has assisted numerous Ardynn members.